Elite Pharmaceuticals, Inc. (ELTP)
0.3788
-0.01
(-3.64%)
USD |
OTCM |
Feb 20, 14:26
Elite Pharmaceuticals Market Cap : 407.02M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.059B |
| Alnylam Pharmaceuticals, Inc. | 45.08B |
| Savara, Inc. | 1.131B |
| BioMarin Pharmaceutical, Inc. | 12.25B |
| Imunon, Inc. | 6.970M |
Market Cap Related Metrics
| PE Ratio | 17.46 |
| PS Ratio | 2.987 |
| Price to Book Value | 5.068 |
| Price to Free Cash Flow | 24.28 |
| Price | 0.3788 |
| Earnings Yield | 5.73% |
| Operating PE Ratio | 8.097 |
| Normalized PE Ratio | 18.94 |